Arbutus Biopharma

News

Moderna's settlement of patent litigation with Arbutus and Genevant over technology used in its Spikevax COVID vaccine could reach up to $2.25bn.

News

Parabilis has set the terms of its IPO, seeking to raise a hefty $475m for phase 3 trials of its lead drug for desmoid tumours.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.